• August 28, 2017

    VHA Advances ASAM Follow-Up Measure

    ASAM’s Journal of Addiction Medicine recently published the Predictive Validity of Outpatient Follow-up After Detoxification as a Quality Measure study in its May/June issue, which evaluated the predictive validity of a 7-day outpatient follow-up after detoxification quality measure used by the Veterans Health Administration (VHA).
  • August 3, 2017

    ASAM Applauds Senate Approval of Dr. Elinore McCance-Katz as First Assistant Secretary for Mental Health and Substance Use

    U.S. Senate confirmed Dr. Elinore McCance-Katz as the first Assistant Secretary for Mental Health and Substance Use.
  • July 28, 2017

    ASAM Announces 2017 ASAM Annual Fellowship Award

    Simeon Kimmel, MD, of Boston University to receive honor and award on July 28th in Dallas, Texas.
  • July 11, 2017

    ASAM Releases Consensus Document Outlining Appropriate Use of Drug Testing

    Practical guidance on the use of drug testing across the many clinical settings in which addiction treatment is provided.
  • June 23, 2017

    ASAM Urges Senate to Reject Harmful Health Care Bill

    The American Society of Addiction Medicine (ASAM) urges the Senate to reject the health reform bill unveiled today by Senate leadership. The Better Care Reconciliation Act (BCRA), like the House-passed American Health Care Act, would devastate access to addiction treatment services in the midst of our nation’s ongoing opioid addiction and overdose epidemic.
  • May 2, 2017

    ASAM Congratulates Dr. McLellan for NIAAA-NIDA Lifetime Science Award

    The American Society of Addiction Medicine (ASAM) would like to congratulate A. Thomas McLellan, PhD, Founder and Board Chair, Treatment Research Institute (TRI) in Philadelphia, PA, who will receive the first NIAAA-NIDA Lifetime Science Award for his outstanding contribution to the field of drug and alcohol research on May 3, 2017
  • April 18, 2017

    Addiction Treatment Gap Awareness Week Starts April 24th

    The American Society of Addiction Medicine (ASAM) will be hosting the first ever Addiction Treatment Gap Awareness Week April 24th to 30th, 2017. This national awareness week will be dedicated to recognizing the significant gap in treatment for those with the disease of addiction.
  • March 9, 2017

    ASAM Letter To Congress Regarding Proposed Changes To The Affordable Care Act.

    ASAM is very concerned that the AHCA’s proposed changes to our health care system will result in reductions in health care coverage, particularly for vulnerable populations including those suffering from the chronic disease of addiction.
  • February 23, 2017

    ASAM and NJSAM Comment on the Passage of Legislation Mandating Six Months of Addiction Treatment in New Jersey

    On Wednesday, February 15, Gov. Christie signed into law a sweeping piece of legislation that mandates insurance coverage for up to six months of inpatient and outpatient addiction treatment, as well as imposes a five-day limit on initial opioid prescriptions for acute pain and requires continuing medical education for prescribers on opioid misuse.
  • February 20, 2017

    ASAM applauds announcement of new addiction medicine board examination in fall of 2017

    Starting in the fall of 2017, ABPM will offer physicians who are certified by a Member Board of the American Board of Medical Specialties (ABMS) the opportunity to become certified in the subspecialty of addiction medicine.
  • January 24, 2017

    ASAM Thanks Anthem and New York Attorney General Schneiderman

    he American Society of Addiction Medicine (ASAM) commends Anthem and New York Attorney General Eric Schneiderman for securing a national agreement to no longer require prior authorization for medications to treat addiction involving opioid use.
  • January 17, 2017

    ASAM Announces Partnerships to Offer Free Training for NPs and PAs to Treat Opioid Addiction

    New partnership with the American Association of Nurse Practitioners (AANP) and the American Academy of PAs (AAPA) offers new training courses that will allow physician assistants (PAs) and nurse practitioners (NPs) to prescribe buprenorphine, a medication to treat addiction involving opioid use.
  • December 7, 2016

    The 21st Century Cures Act - Highlights for ASAM Members

    On December 13, President Obama signed the 21st Century Cures Act, a sweeping biomedical innovation bill that includes several legislative changes that will impact the field of addiction medicine. Read on for the highlights for ASAM members.
  • December 2, 2016

    MACRA Final Rule Released

    In mid-October, CMS released the final rule about implementation of the Medicare Access and CHIP Reauthorization Act (MACRA). This new Medicare payment program will replace the Sustainable Growth Rate (SGR) that was repealed in 2015. MACRA emphasizes improving quality of care for patients and moving away from a fee-for-service payment system.
  • December 1, 2016

    ASAM Applauds Senate Passage of the ECHO Act

    On November 29, the U.S. Senate voted to pass the Expanding Capacity for Health Outcomes (ECHO) Act. The ECHO Act, introduced by Sens. Hatch (R-UT) and Schatz (D-HI), aims to better integrate the Project ECHO model of technology-enabled collaborative learning and capacity-building into health systems across the country.